Sign in

CIK 0001698530

  • Non-accelerated filer
  • Smaller reporting company

EXICURE, INC.

Sign in to watch
Ticker
XCUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
815333008
Phone
+1 847-673-1707
Business address
2430 N. HALSTED ST., CHICAGO, IL, 60614
Former names
Max-1 Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-09-26 Venkatesan Jay Director Grant or award · Stock Option (right to buy) +12,929 12,929
2017-09-26 Venkatesan Jay Director Grant or award · Stock Option (right to buy) +24,824 24,824
2017-09-26 Kandimalla Ekambarswara R Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +281,915 281,915
2017-09-22 Jacobs Ian Seth President, Secretary, CEO, CFO Grant or award +38,160 103,160
2017-09-22 Tompkins Mark N. Director Grant or award +659,000 1,659,000
2017-09-22 Tompkins Mark N. Director Grant or award +43,160 108,160
2017-06-15 Tompkins Mark N. Director Grant or award +65,000 $0.03 $2K 965,000
2017-06-15 Tompkins Mark N. Director Purchase +35,000 $0.03 $875 1,000,000
2017-06-15 Tompkins Mark N. Director Grant or award +65,000 $0.03 $2K 65,000
2017-06-15 Jacobs Ian Seth President, Secretary, CEO, CFO Sale −35,000 $0.03 $875 65,000

Page 8 of 8 · 150 trades